Pablo Tebas

Pablo Tebas

UNVERIFIED PROFILE

Are you Pablo Tebas?   Register this Author

Register author
Pablo Tebas

Pablo Tebas

Publications by authors named "Pablo Tebas"

Are you Pablo Tebas?   Register this Author

100Publications

2556Reads

45Profile Views

Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Chest 2018 01 18;153(1):266-277. Epub 2017 Sep 18.

Division of Infectious Diseases and Fecal Microbiota Transplantation Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2017.09.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812771PMC
January 2018

Racial differences in calculated bioavailable vitamin D with vitamin D/calcium supplementation.

AIDS 2017 11;31(17):2337-2344

aColumbia University Medical Center, New York City, New York bHarvard T.H. Chan School of Public Health, Boston, Massachusetts cJohns Hopkins University School of Medicine, Baltimore, Maryland dHospital of the University of Pennsylvania, Philadelphia, Pennsylvania eCase Western Reserve University, Cleveland, Ohio fGilead Sciences, Foster City, California gBristol-Myers Squibb, Plainsboro, Middlesex County, New Jersey hDuke University Community Advisory Board, Durham, North Carolina iUniversity of Alabama, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001621DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656526PMC
November 2017

Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report.

N Engl J Med 2017 Oct 4. Epub 2017 Oct 4.

From the Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania (P.T.), and Wistar Institute (K.M., E.L.R., S.B.K., F.I.Z., H.C., D.B.W.), Philadelphia, and Inovio Pharmaceuticals, Plymouth Meeting (S.W., A.S.K., J.B., M.B.) - all in Pennsylvania; GeneOne Life Science, Seoul, South Korea (C.C.R., Y.K.P., C.R., S.E.S., J.N.M.); Infectious Diseases Research Centre-Université Laval, Quebec, QC, Canada (T.R., S.T., G.P.K.); QPS-Miami Research Associates, Miami, (D.K.); and the Department of Medicine, Morristown Medical Center, Morristown, NJ (J.N.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1708120DOI Listing
October 2017

Antiinflammatory effects of aprepitant coadministration with cART regimen containing ritonavir in HIV-infected adults.

JCI Insight 2017 10 5;2(19). Epub 2017 Oct 5.

Department of Pediatrics, Children's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/jci.insight.95893DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841871PMC
October 2017

Current use of statins reduces risk of HIV rebound on suppressive HAART.

PLoS One 2017 1;12(3):e0172175. Epub 2017 Mar 1.

Infectious Diseases Section, Medical Service, VA North Texas Health Care System, Dallas, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0172175PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331966PMC
August 2017

Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.

J Acquir Immune Defic Syndr 2017 Feb;74(2):180-184

*Department of Sexual Health, King's College Hospital NHS Foundation Trust, London, United Kingdom; †Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ‡Department of Sexual Health, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom; §Department of Infectious Diseases, Croix-Rousse Hospital, Hospices Civils de Lyon, France; and ‖Gilead Sciences, Inc., Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001186DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228610PMC
February 2017

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults.

J Acquir Immune Defic Syndr 2017 Feb;74(2):193-200

*The Ruth M. Rothstein CORE Center, Chicago, IL; †Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ‡Southwest CARE Center, Santa Fe, NM; §Division of Infectious Diseases, Weill Cornell Medicine, New York, NY; and ‖Gilead Sciences, Inc., Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228611PMC
February 2017

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.

N Engl J Med 2016 11 9;375(21):2037-2050. Epub 2016 Nov 9.

From the University of Pennsylvania (K.J.B., D.B.S., B.S., G.H.L., E.F.K., M.B., J.A.H., P.T.) and Children's Hospital of Philadelphia (N.B.T.) - both in Philadelphia; the Laboratory of Immunoregulation (M.C.S., J.S.J., M.E.P., J.B., E.W.R., K.E.C., S.M., A.S.F., T.-W.C.), Biostatistics Research Branch (M.A.P.), Vaccine Research Center (P.J.M., S.J.O., A.R.S., N.A.D.-R., R.T.B., J.E.L., R.M.L., B.S.G., R.A.K., J.R.M.), and Division of AIDS (R.L.T.), National Institute of Allergy and Infectious Diseases and National Institutes of Health (NIH), and the Critical Care Medicine Department, Clinical Center, NIH (C.A.S., R.W.K.), Bethesda, the AIDS Clinical Trials Group, Silver Spring (K.O.), and Columbus Technologies and Services, Greenbelt (R.L.T.) - all in Maryland; Harvard T.H. Chan School of Public Health, Boston (L.J.H.); the University of Alabama at Birmingham, Birmingham (E.T.O., M.M.); Frontier Science and Technology Research Foundation, Amherst, NY (B.J.); and the University of California, San Diego, La Jolla (E.V.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1608243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292134PMC
November 2016

Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results.

J Acquir Immune Defic Syndr 2016 May;72(1):58-64

*Department of Medicine, University of North Carolina, Chapel Hill, NC; †AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan; ‡Department of Infectious Diseases, CHU Saint-Pierre University Hospital Brussels, Brussels, Belgium; §Elton John centre, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom; ‖Central Texas Clinical Research, Austin, TX; ¶Department of Internal Medicine, Mercer University School of Medicine, Macon, GA; #The Miriam Hospital, Alpert Medical School of Brown University, Providence, RI; **Infectious Diseases Unit, Internal Medicine Service, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain; ††Capital Center for Travel and Tropical Medicine, Washington, DC; ‡‡Internal Medicine Unit, Le Kremlin-Bicêtre Hospital, AP-HP Infectious Diseases Unit, Centre Hospitalier de Tourcoing Descartes University, Necker Hospital, AP-HP, Paris, France; §§Medicine, Maple Leaf Research, Department of Family and Community Medicine, University of Toronto, Toronto, CA; ‖‖Clinica delle Malattie Infettive e Tropicali, University of Modena and Reggio Emilia, Modena, Italy; ¶¶Department of Medicine and Center for AIDS Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ##Division of Infectious Diseases and Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; and ***Gilead Sciences, Foster City, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000940DOI Listing
May 2016

Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease.

AIDS 2016 Feb;30(4):601-8

aVA North Texas Health Care System bUniversity of Texas Southwestern Medical Center, Dallas, Texas cUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000952DOI Listing
February 2016

The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection.

J Acquir Immune Defic Syndr 2016 Feb;71(2):163-71

*Division of Infectious Diseased and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA;†Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA;‡Division of Infectious Diseases, University of Colorado, Denver, CO;§Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA;‖Profectus BioSciences, Inc., Tarrytown, NY;¶Department of Immunology and Microbiology, Rush University School of Medicine, Chicago, IL;#Department of Neurology, Washington University School of Medicine, St. Louis, MO;**HIV/AIDS Division, University of California, San Francisco, CA;††Social and Scientific Systems, Inc., Silver Springs, MD;‡‡Division of AIDS, NIAID, Bethesda, MD;§§Frontier Science, Amherst, NY; and‖‖Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000830DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712745PMC
February 2016

Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks.

AIDS 2015 Nov;29(18):2459-64

aUniversity of Pennsylvania, Philadelphia, Pennsylvania bGeorgetown University School of Medicine, Washington, District of Columbia cUniversity of California San Diego Owen Clinic, San Diego, California, USA dGlaxoSmithKline, London, UK eGlaxoSmithKline, Philadelphia, Pennsylvania fGlaxoSmithKline, Research Triangle Park, North Carolina gViiV Healthcare, Research Triangle Park, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000863DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645955PMC
November 2015

Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected Persons.

AIDS Res Treat 2015 12;2015:653840. Epub 2015 Oct 12.

Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://downloads.hindawi.com/journals/art/2015/653840.pdf
Web Search
http://www.hindawi.com/journals/art/2015/653840/
Publisher Site
http://dx.doi.org/10.1155/2015/653840DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630342PMC
November 2015

Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.

J Infect Dis 2015 Sep 9;212(6):924-33. Epub 2015 Mar 9.

Division of Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology Department of Pediatrics and Medicine, Stanford University, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiv147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548465PMC
September 2015

Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients.

Kidney Int 2015 Aug 25;88(2):341-9. Epub 2015 Mar 25.

Department of Medicine, Division of Renal Electrolyte and Hypertension, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2015.74DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113138PMC
August 2015

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

N Engl J Med 2015 Aug 21;373(8):705-13. Epub 2015 Jul 21.

From Duke Clinical Research Institute, Durham, NC (S.N.); University of Ottawa, the Ottawa Hospital, Ottawa (C.C.), and Department of Hepatology, Immunodeficiency Clinic, Toronto General Hospital, University of Toronto, Toronto (D.K.W.) - both in Canada; University of Alabama at Birmingham, Birmingham (M. Saag); Emory University, Emory Healthcare, Atlanta (K.W.); Ruane Medical and Liver Health Institute (P.R.) and Kaiser Permanente Los Angeles Medical Center (W.J.T.), Los Angeles, University of California, San Francisco, San Francisco General Hospital, San Francisco (A.L.), and Gilead Sciences, Foster City (L.M.S., J.C.Y., P.G., H.D.-S., L.N., P.S.P., J.G.M.) - all in California; Weill Cornell Medical College (K.M.), Icahn School of Medicine at Mount Sinai (N.B., D.D.), New York, and James J. Peters Veterans Affairs Medical Center, Bronx (N.B.) - all in New York; Beth Israel Deaconess Medical Center (R.P.B.), Brigham and Women's Hospital and Harvard Medical School (P.E.S.), and Community Research Initiative of New England (A.E.C.) - all in Boston; University of Auckland, Auckland City Hospital, Auckland (E.G.), and Christchurch Hospital and University of Otago, Christchurch (C.A.M.S.) - both in New Zealand; University of Puerto Rico School of Medicine (J.S.-B.) and Clinical Research Puerto Rico (J.O.M.-R.) - both in San Juan; University of Miami, Miami (D.J.); University of Pennsylvania, Philadelphia (P.T.); and Johns Hopkins University School of Medicine, Baltimore (M. Sulkowski).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1501315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892372PMC
August 2015

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults.

AIDS 2015 May;29(8):931-9

aDepartment of Medicine bDepartment of Pediatrics cDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania dThe Children's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania eWestat, Rockville, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000638DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472318PMC
May 2015

Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitant.

Curr HIV Res 2014 ;12(2):121-31

Divisions of Clinical Pharmacology and Therapeutics, The Children's Hospital of Philadelphia Research Institute, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
March 2015

A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy.

J Acquir Immune Defic Syndr 2014 Aug;66(4):399-406

*Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA; †AIDS Clinical Trials Group, Statistical and Data Analysis Center, Harvard University School of Public Health, Boston, MA; ‡Vaccine and Gene Therapy Institute, Port Saint Lucie, FL; §Department of Radiology, University of Michigan School of Medicine, Ann Arbor, MI; ‖Department of Immunology/Microbiology, Rush University School of Medicine, Chicago, IL; ¶Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre, Montreal, CA; #Division of Infectious Diseases, Department of Medicine, University of California, San Diego, School of Medicine, San Diego, CA; **Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; ††Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, PA; ‡‡Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN; §§Social and Scienti\x{fb01}c Systems, Inc., Silver Springs, MD; ‖‖Frontier Sciences, Buffalo, NY; and ¶¶Division of AIDS, NIAID, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216663PMC
August 2014

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

N Engl J Med 2014 Mar;370(10):901-10

From the Perelman School of Medicine, University of Pennsylvania, Philadelphia (P.T., I.F., M.K., R.G.C., G.B.-S., G.P., W.-T.H., B.L.L., C.H.J.); Albert Einstein College of Medicine, Bronx, NY (D.S.); and Sangamo BioSciences, Richmond, CA (W.W.T., S.Q.W., G.L., S.K.S., R.T.S., M.A.G., G.N., M.C.H., P.D.G., D.G.A.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1300662
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1300662DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084652PMC
March 2014

Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants.

AIDS 2014 Jan;28(3):335-44

aNorthwestern University, Feinberg School of Medicine, Chicago, Illinois, USA bBrighton and Sussex University Hospitals, Brighton, UK cUniversity of Pennsylvania, Division of Infectious Diseases, Clinical Trials Unit, Philadelphia, Pennsylvania, USA dChelsea and Westminster Hospital Foundation Trust, London, UK ePeter Ruane, MD, Inc., Los Angeles, California, USA fUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany gLa Playa Medical Group and Clinical Research, San Diego hKaiser Permanente, Sacramento iGilead Sciences Inc., Foster City, California, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000000087DOI Listing
January 2014

Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients.

J Bone Miner Res 2013 Dec;28(12):2577-83

University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbmr.1988DOI Listing
December 2013

Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density.

AIDS 2013 Aug;27(13):2069-79

aUniversity of Colorado-Anschutz Medical Campus; Aurora, Colorado bHarvard School of Public Health, Boston cBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts dLos Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California eUniversity of Pennsylvania, Philadelphia, Pennsylvania fGilead Sciences, Foster City, California gViiV Healthcare, Research Triangle, North Carolina hSocial and Scientific Systems, Inc., Silver Spring, Maryland iCase Western Reserve University, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0b013e328361d25dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966569PMC
August 2013

In vitro and in vivo effects of IGF-I on adiposity in HIV-associated metabolic disease: a pilot study.

Arch Med Res 2013 Jul 16;44(5):361-9. Epub 2013 Jul 16.

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arcmed.2013.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234118PMC
July 2013

Increased fracture risk with HIV infection--a growing concern.

Nat Rev Endocrinol 2013 May 26;9(5):260-1. Epub 2013 Mar 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrendo.2013.62DOI Listing
May 2013

Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.

Clin Infect Dis 2013 Apr 29;56(8):1165-73. Epub 2013 Jan 29.

Department of Medicine, Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, and The Children’s Hospital of Philadelphia, Philadelphia, PA 19104-6021, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/
Publisher Site
http://dx.doi.org/10.1093/cid/cit019DOI Listing
April 2013

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.

Hepatology 2012 Nov 14;56(5):1688-98. Epub 2012 Oct 14.

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.25866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433632PMC
November 2012

Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.

AIDS Res Hum Retroviruses 2012 Oct 2;28(10):1184-95. Epub 2012 Apr 2.

Bellevue Hospital Center at New York University School of Medicine, New York, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448095PMC
October 2012

Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions.

AIDS Care 2012 22;24(6):769-77. Epub 2011 Nov 22.

Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/09540121.2011.6
Publisher Site
http://dx.doi.org/10.1080/09540121.2011.630368DOI Listing
August 2012

Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals.

J AIDS Clin Res 2012 May;3(4):152

Division of General Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4172/2155-6113.1000152DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514974PMC
May 2012

Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy.

J Acquir Immune Defic Syndr 2011 Nov;58(3):297-303

Infectious Diseases Group, Pfizer Global Research and Development, Sandwich, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e31822ccfccDOI Listing
November 2011

Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.

Clin Infect Dis 2011 Jul;53(1):84-91

VA North Texas Health Care System, University of Texas Southwestern Medical Center, Dallas, Texas 75216, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/
Publisher Site
http://dx.doi.org/10.1093/cid/cir269DOI Listing
July 2011

Aging and HIV infection: a comparison between older HIV-infected persons and the general population.

HIV Clin Trials 2010 Mar-Apr;11(2):100-9

Washington University, School of Medicine, St. Louis, Missouri 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1310/hct1102-100DOI Listing
July 2010

Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men.

AIDS 2009 Oct;23(16):2191-8

Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e32832ec258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837269PMC
October 2009

Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells.

Mol Ther 2009 May 3;17(5):844-50. Epub 2009 Mar 3.

Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6076, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2009.16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835137PMC
May 2009

HIV and cardiometabolic abnormalities: new perspectives and treatment update.

Authors:
Pablo Tebas

J Acquir Immune Defic Syndr 2008 Sep;49 Suppl 2:S77-8

University of Pennsylvania, AIDS Clinical Trials Unit, Philadelphia, PA 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3181865113DOI Listing
September 2008

Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options.

Authors:
Pablo Tebas

J Acquir Immune Defic Syndr 2008 Sep;49 Suppl 2:S86-92

AIDS Clinical Trials Unit, University of Pennsylvania, Philadelphia, PA 19104-4283, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e31818651e6DOI Listing
September 2008

Massively parallel pyrosequencing in HIV research.

AIDS 2008 Jul;22(12):1411-5

Department of Microbiology, University of Pennsylvania School of Medicine, 3610 Hamilton Walk, Philadelphia, PA 19104-6076, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e3282fc972eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221253PMC
July 2008